Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of 2-bromide-isovanillin for the manufacture of a medicament for anti-cancer or/and radiation/chemotherapy sensitization

a technology of isovanillin and bromide, which is applied in the field of compounds, can solve the problems of serious endangerment of human health and no effective treatment or prophylaxis yet available, and achieves the effect of improving the safety and efficacy of the produ

Active Publication Date: 2008-09-11
INST OF RADIATION MEDICINE ACAD OF MILITARY MEDICAL SCI OF THE PLA
View PDF6 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention is about a new compound called 2-bromo-isovanillin, which has strong anticancer and radio- and chemotherapy sensitizing effects. It can be used to make medications for cancer treatment and sensitization. The compound has low toxicity and can inhibit the growth of cancer cells and induce their death. It can also be combined with other drugs to enhance their effects and reduce toxicity. The compound is convenient to use and can be taken orally. Overall, this new compound has unique properties that make it a promising treatment for cancer."

Problems solved by technology

Malignant tumor is one of those diseases that seriously endanger human health.
Currently, no effective treatment or prophylaxis is yet available.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of 2-bromide-isovanillin for the manufacture of a medicament for anti-cancer or/and radiation/chemotherapy sensitization
  • Application of 2-bromide-isovanillin for the manufacture of a medicament for anti-cancer or/and radiation/chemotherapy sensitization
  • Application of 2-bromide-isovanillin for the manufacture of a medicament for anti-cancer or/and radiation/chemotherapy sensitization

Examples

Experimental program
Comparison scheme
Effect test

example 1

Screening of Vanillin Derivatives Exhibiting a Remarkable Inhibitory Effect on the Proliferation of Cancer Cells

1. Effect of Vanillin on the Proliferation of Cancer Cells as Measured by MTT Assay

[0032]By way of example, human cervical cancer cell line HeLa was used to study the effect of vanillin on the proliferation of cancer cells by MTT assay. Specifically, human cervical cancer cells HeLa were seeded into a 96-well plate at a density of 5×103 cells / well, and were divided into four groups. To each of the groups vanillin was added at a concentration of 0, 100, 250 or 500 μmol / L, respectively, and was allowed to grow for 4 days. Using the MTT assay, the optical density (OD) values at 490 nm were measured and recorded every day, wherein the OD value is indicative of the number of cells, i.e., the proliferation of cells. The results, as shown in FIG. 1A, indicated that vanillin effectively inhibited the proliferation of cancer cells at a concentration above 250 μmol / L.

2. Effect of Va...

example 2

2-bromo-isovanillin Inhibited Proliferation and Induced Apoptosis in Cancer Cells

[0036]The effect of 2-bromo-isovanillin in inhibiting proliferation and inducing apoptosis in solid tumor cells of different tissue origins was investigated by clonogenic assay as follows:

1. Determination of the Killing of Cancer Cells by 2-Bromo-Isovanillin for 6 Days

[0037]By way of example, human cervical cancer cell line HeLa, lung cancer cell line A549, and ovarian cancer cell lines A2780 and HOC8 were used to determine the killing of cancer cells by 2-bromo-isovanillin for 6 days. Specifically, four groups were formed according to the type of the cancer cells. The cancer cells were diluted as appropriate, and were respectively plated into Petri dishes with a diameter of 60 cm, the amount of the cells adjusted depending on the concentration of 2-bromo-isovanillin to be added. Once adherence was achieved, each cell type received dosages of 0, 5, 10, 15, 20, 25, 30 and 35 μmol / L in triplicates. After ...

example 3

Determination of the Radiosensitizing Activity of 2-bromo-isovanillin

[0039]By way of example, human cervical cancer cell line HeLa was used to determine the radiosensitizing activity of 2-bromo-isovanillin.

[0040]Specifically, human cervical cancer cells HeLa were divided into six groups, diluted as appropriate, and plated into Petri dishes with a diameter of 60 cm. The amount of cells plated in each Petri dish was 300 / 500 for 0 Gy group (without Co-60 γ radiation), or 400 / 800 for 2 Gy group. Once adherence was achieved, three groups were treated with 20 μmol / L 2-bromo-isovanillin (BVAN3208) for 0, 4 and 18 hrs, respectively and then irradiated with Co-60 γ ray at 2 Gy, followed by two weeks under conventional culturing conditions. As to the other three groups, one group was treated with 20 μmol / L 2-bromo-isovanillin (BVAN3208) for 72 hrs and then cultured for two weeks under conventional conditions, one group received irradiation with Co-60 γ ray at 2 Gy and then was cultured for tw...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
weightaaaaaaaaaa
timeaaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

Use of 2-bromo-isovanillin in the preparation of an anticancer medicament and / or radio- and chemotherapy sensitizing medicament is disclosed. The medicament for the treatment of cancers and / or for radio- and chemotherapy sensitization comprising 2-bromo-isovanillin as active ingredient provided herein has the following features: (1) low toxicity, without evident adverse effects; (2) significant therapeutic effect, with remarkable proliferation inhibiting and pro-apoptotic effects in tumor cells; (3) a broad-spectrum anticancer activity; (4) suitable to be used in combination with antimetabolites, to enhance the effects and meanwhile lower the toxicity, and also to reduce multi-drug resistance; (5) convenient and safe administration, the main route being oral.

Description

TECHNICAL FIELD[0001]The present invention relates to a new use of a compound, in particular to use of 2-bromo-isovanillin, a derivative of vanillin, in the preparation of an anticancer medicament and / or radio- and chemotherapy sensitizing medicament.BACKGROUND ART[0002]Malignant tumor is one of those diseases that seriously endanger human health. Currently, no effective treatment or prophylaxis is yet available. Thus, it is still the predominant task in the treatment of tumor to search for an effective preventive and / or therapeutic agent.[0003]Vanillin compounds have aromatic odor, exhibit inhibition of bacterial growth and refreshing effect, and thus have been widely used as a food additive. Studies showed that vanillins, at a certain concentration, could also inhibit the activity of DNA repairing proteins DNA-PKcs and the invasion of cancer cells (Durant S and Karran P. Vanillins—a novel family of DNA-PK inhibitors. Nucleic Acids Research, 2003, 31(19): 5501-5512.; Tsuda H, Uehar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/11A61P35/04
CPCA61K31/11A61P35/00A61P35/04
Inventor ZHOU, PINGKUNYAN, YUQIANWANG, LINSUI, JIANLI
Owner INST OF RADIATION MEDICINE ACAD OF MILITARY MEDICAL SCI OF THE PLA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com